Breaking News Instant updates and real-time market news.

VIX

Volatility Index S&P 500 Options

/

+

16:20
06/24/21
06/24
16:20
06/24/21
16:20

Closing CBOE SPX and VIX Index summary for June 24th

The CBOE Volatility Index (VIX), the SPX option derived measure of implied volatility, fell 0.35 today to close at 15.97, while the underlying SPX index gained 24.65 to close at $4266.49, a 0.58% increase. 372,059 VIX option contracts traded, 76.15% of the typical daily volume for the product. Calls made up 64.9% of the volume.

TODAY'S FREE FLY STORIES

Earnings
Chimerix reports Q2 EPS (21c), consensus (19c) » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
CMRX

Chimerix

$6.48 /

-0.2 (-2.99%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

06/07/21 H.C. Wainwright
Chimerix price target raised to $19 from $18 at H.C. Wainwright
05/06/21 H.C. Wainwright
Chimerix price target raised to $18 from $16 at H.C. Wainwright
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 Maxim
Chimerix initiated with a Buy at Maxim
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

  • 21
    Jan
Earnings
Aptiv raises FY21 EPS view to $3.63-$3.87 from $3.35-$3.85, consensus $3.74 » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
APTV

Aptiv

$165.66 /

-3.49 (-2.06%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

07/15/21 Deutsche Bank
Aptiv price target raised to $169 from $165 at Deutsche Bank
07/09/21 Jefferies
Aptiv price target raised to $182 from $170 at Jefferies
07/07/21 Barclays
Aptiv price target raised to $164 from $161 at Barclays
06/24/21 Guggenheim
Aptiv upgraded to Buy from Neutral at Guggenheim
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

Earnings
Quotient reports Q1 EPS (24c), consensus (27c) » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
QTNT

Quotient

$3.58 /

+0.16 (+4.68%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

QTNT Quotient
$3.58 /

+0.16 (+4.68%)

06/03/21 Goldman Sachs
Quotient initiated with a Neutral at Goldman Sachs
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

  • 11
    Sep
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

Recommendations
TechTarget price target raised to $90 from $80 at Deutsche Bank » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
TTGT

TechTarget

$73.28 /

+0.63 (+0.87%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

07/07/21 Sidoti
TechTarget initiated with a Buy at Sidoti
06/30/21 JPMorgan
TechTarget initiated with a Neutral at JPMorgan
06/23/21
Fly Intel: Top five analyst initiations
06/23/21 Deutsche Bank
TechTarget initiated with a Buy at Deutsche Bank
TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

Hot Stocks
Robinhood down 11% after filing to sell up to 97.88M shares for shareholders » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
HOOD

Robinhood

$70.50 /

+23.8 (+50.96%)

Robinhood shares are down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

07/29/21
Fly Intel: Top five analyst initiations
07/29/21 Atlantic Equities
Robinhood initiated with an Overweight at Atlantic Equities
  • 29
    Jul
HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

Earnings
Antares Pharma sees 2021 revenue $175M-$200M, consensus $187.96M » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
ATRS

Antares Pharma

$4.25 /

-0.13 (-2.97%)

The Company today…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

07/16/21 Truist
Truist starts Antares Pharma with Buy, $7 price target
07/16/21 Truist
Antares Pharma initiated with a Buy at Truist
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

Earnings
Duke Energy backs FY21 adjusted EPS view $5.00-$5.30, consensus $5.18 » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
DUK

Duke Energy

$106.59 /

+ (+0.00%)

Backs long-term adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

07/13/21 Credit Suisse
Duke Energy assumed with a Neutral at Credit Suisse
06/25/21 Argus
Duke Energy upgraded to Buy from Hold at Argus
06/17/21 RBC Capital
SC rejection a potential read-through for Duke NC IRP process, says RBC Capital
05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

Recommendations
Electronic Arts price target raised to $177 from $175 at Deutsche Bank » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
EA

Electronic Arts

$139.79 /

+0.04 (+0.03%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

07:04 Today Baird
Electronic Arts price target raised to $170 from $160 at Baird
08/02/21 Credit Suisse
Electronic Arts price target raised to $174 from $165 at Credit Suisse
07/21/21
Fly Intel: Top five analyst upgrades
07/21/21 Deutsche Bank
Deutsche names Electronic Arts top pick in video games, upgrades to Buy
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

Recommendations
Electronic Arts price target raised to $170 from $160 at Baird » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
EA

Electronic Arts

$139.79 /

+0.04 (+0.03%)

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

08/02/21 Credit Suisse
Electronic Arts price target raised to $174 from $165 at Credit Suisse
07/21/21
Fly Intel: Top five analyst upgrades
07/21/21 Deutsche Bank
Deutsche names Electronic Arts top pick in video games, upgrades to Buy
07/21/21 Deutsche Bank
Electronic Arts upgraded to Buy from Hold at Deutsche Bank
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

Earnings
Antares Pharma reports Q2 EPS 3c, consensus 1c » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
ATRS

Antares Pharma

$4.25 /

-0.13 (-2.97%)

Reports Q2 revenue $45M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

07/16/21 Truist
Truist starts Antares Pharma with Buy, $7 price target
07/16/21 Truist
Antares Pharma initiated with a Buy at Truist
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

Hot Stocks
Passage Bio expects cash balance to fund operations for next 24 months » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Duke Energy reports Q2 adjusted EPS $1.15, consensus $1.09 » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
DUK

Duke Energy

$106.59 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

07/13/21 Credit Suisse
Duke Energy assumed with a Neutral at Credit Suisse
06/25/21 Argus
Duke Energy upgraded to Buy from Hold at Argus
06/17/21 RBC Capital
SC rejection a potential read-through for Duke NC IRP process, says RBC Capital
05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

Recommendations
Rimini Street price target lowered to $10 from $12 at Alliance Global Partners » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
RMNI

Rimini Street

$8.28 /

-0.29 (-3.38%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

05/11/21 Roth Capital
Rimini Street downgraded to Neutral at Roth Capital
05/11/21 Roth Capital
Rimini Street downgraded to Neutral from Buy at Roth Capital
02/02/21 Craig-Hallum
Rimini Street price target raised to $11 from $6 at Craig-Hallum
02/02/21 Roth Capital
Rimini Street price target raised to $15 from $10 at Roth Capital
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

  • 09
    Mar
  • 14
    Aug
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

Earnings
Wayfair reports Q2 EPS $1.89, consensus $1.17 » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
W

Wayfair

$251.27 /

+1.78 (+0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

08/02/21 JPMorgan
Wayfair price target lowered to $200 from $240 at JPMorgan
07/16/21 Exane BNP Paribas
Wayfair initiated with an Outperform at Exane BNP Paribas
07/09/21 Jefferies
Wayfair price target raised to $355 from $350 at Jefferies
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

Hot Stocks
Passage Bio announces anticipated upcoming milestones » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

Dose first patient in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Passage Bio reports Q2 EPS (90c), consensus (76c) » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

"As we advance our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Aptiv reports Q2 EPS 60c, consensus 69c » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
APTV

Aptiv

$165.66 /

-3.49 (-2.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

07/15/21 Deutsche Bank
Aptiv price target raised to $169 from $165 at Deutsche Bank
07/09/21 Jefferies
Aptiv price target raised to $182 from $170 at Jefferies
07/07/21 Barclays
Aptiv price target raised to $164 from $161 at Barclays
06/24/21 Guggenheim
Aptiv upgraded to Buy from Neutral at Guggenheim
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

Earnings
ProQR Therapeutics reports Q2 EPS (EUR0.24) vs. (EUR0.08) last year » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
PRQR

ProQR Therapeutics

$5.96 /

+0.14 (+2.41%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRQR ProQR Therapeutics
$5.96 /

+0.14 (+2.41%)

PRQR ProQR Therapeutics
$5.96 /

+0.14 (+2.41%)

05/03/21 Stifel
ProQR Therapeutics initiated with a Buy at Stifel
03/25/21 Citi
ProQR Therapeutics price target raised to $44 from $33 at Citi
03/24/21 Cantor Fitzgerald
ProQR Therapeutics price target raised to $33 from $22 at Cantor Fitzgerald
03/24/21 JMP Securities
ProQR Therapeutics price target raised to $35 from $19 at JMP Securities
PRQR ProQR Therapeutics
$5.96 /

+0.14 (+2.41%)

  • 31
    Mar
PRQR ProQR Therapeutics
$5.96 /

+0.14 (+2.41%)

Hot Stocks
Growth Capital Acquisition Corporation (Units) trading halted, news pending  07:02
08/05/21
08/05
07:02
08/05/21
07:02
 
Hot Stocks
Growth Capital Acquisition Corporation (Class A Stock) trading halted, news pending  07:02
08/05/21
08/05
07:02
08/05/21
07:02
GCAC

Growth Capital Acquisition

$9.72 /

-0.04 (-0.41%)

 
Recommendations
Triumph Group designated a bullish Fresh Pick at Baird » 07:02
08/05/21
08/05
07:02
08/05/21
07:02
TGI

Triumph Group

$17.08 /

-2.515 (-12.84%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGI Triumph Group
$17.08 /

-2.515 (-12.84%)

TGI Triumph Group
$17.08 /

-2.515 (-12.84%)

06/18/21 Truist
Triumph Group price target raised to $30 from $21 at Truist
05/21/21 Canaccord
Triumph Group price target raised to $15 from $13 at Canaccord
03/04/21 BofA
Triumph Group upgraded to Buy from Neutral at BofA
02/04/21 Baird
Triumph Group upgraded to Outperform at Baird ahead of 'major catalysts'
TGI Triumph Group
$17.08 /

-2.515 (-12.84%)

TGI Triumph Group
$17.08 /

-2.515 (-12.84%)

Earnings
Karuna Therapeutics reports Q2 EPS ($1.17), consensus ($1.35) » 07:02
08/05/21
08/05
07:02
08/05/21
07:02
KRTX

Karuna Therapeutics

$108.03 /

-1.21 (-1.11%)

"Q2 was an exciting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
06/30/21 Mizuho
Karuna selloff on Cerevel data 'appears overdone,' says Mizuho
KRTX Karuna Therapeutics
$108.03 /

-1.21 (-1.11%)

  • 02
    Mar
Recommendations
Rapid7 price target raised to $130 from $115 at Barclays » 07:01
08/05/21
08/05
07:01
08/05/21
07:01
RPD

Rapid7

$116.34 /

+0.92 (+0.80%)

Barclays analyst Saket…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

06:51 Today Mizuho
Rapid7 price target raised to $125 from $110 at Mizuho
08/02/21
Fly Intel: Top five analyst initiations
08/02/21 KeyBanc
Rapid7 initiated with an Overweight at KeyBanc
07/20/21 RBC Capital
Rapid7 price target raised to $120 from $110 at RBC Capital
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

Recommendations
MercadoLibre price target raised to $2,100 from $2,000 at Barclays » 07:01
08/05/21
08/05
07:01
08/05/21
07:01
MELI

MercadoLibre

$1,568.48 /

+4.62 (+0.30%)

Barclays analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MELI MercadoLibre
$1,568.48 /

+4.62 (+0.30%)

MELI MercadoLibre
$1,568.48 /

+4.62 (+0.30%)

08/03/21 Credit Suisse
MercadoLibre price target raised to $2,050 from $1,824 at Credit Suisse
07/20/21 William Blair
New partnerships align with BigCommerce open SaaS strategy, says William Blair
07/09/21 DZ Bank
MercadoLibre initiated with a Buy at DZ Bank
06/07/21 Citi
MercadoLibre price target raised to $2,250 from $2,150 at Citi
MELI MercadoLibre
$1,568.48 /

+4.62 (+0.30%)

MELI MercadoLibre
$1,568.48 /

+4.62 (+0.30%)

Earnings
Primo Water raises FY21 revenue view to up 6% from up 5%, consensus $2.07B » 07:00
08/05/21
08/05
07:00
08/05/21
07:00
PRMW

Primo Water

$16.21 /

-0.275 (-1.67%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRMW Primo Water
$16.21 /

-0.275 (-1.67%)

PRMW Primo Water
$16.21 /

-0.275 (-1.67%)

05/07/21 CIBC
Primo Water price target raised to $18.50 from $18 at CIBC
05/03/21 Deutsche Bank
Primo Water price target raised to $19 from $17 at Deutsche Bank
03/09/21
Fly Intel: Top five analyst upgrades
03/09/21 Scotiabank
Primo Water upgraded to Outperform from Sector Perform at Scotiabank
PRMW Primo Water
$16.21 /

-0.275 (-1.67%)

PRMW Primo Water
$16.21 /

-0.275 (-1.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.